These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21515428)

  • 1. Advances in the production and downstream processing of antibodies.
    Chon JH; Zarbis-Papastoitsis G
    N Biotechnol; 2011 Sep; 28(5):458-63. PubMed ID: 21515428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in large-scale production of monoclonal antibodies and related proteins.
    Shukla AA; Thömmes J
    Trends Biotechnol; 2010 May; 28(5):253-61. PubMed ID: 20304511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines to cell engineering for monoclonal antibody production.
    Rita Costa A; Elisa Rodrigues M; Henriques M; Azeredo J; Oliveira R
    Eur J Pharm Biopharm; 2010 Feb; 74(2):127-38. PubMed ID: 19853660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals.
    Butler M
    Appl Microbiol Biotechnol; 2005 Aug; 68(3):283-91. PubMed ID: 15834715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technological progresses in monoclonal antibody production systems.
    Rodrigues ME; Costa AR; Henriques M; Azeredo J; Oliveira R
    Biotechnol Prog; 2010; 26(2):332-51. PubMed ID: 20043321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of advanced technologies in commercial monoclonal antibody production.
    Zhou JX; Tressel T; Yang X; Seewoester T
    Biotechnol J; 2008 Oct; 3(9-10):1185-200. PubMed ID: 18759247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
    Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-use purification process for the production of a monoclonal antibody produced in a PER.C6 human cell line.
    Kuczewski M; Schirmer E; Lain B; Zarbis-Papastoitsis G
    Biotechnol J; 2011 Jan; 6(1):56-65. PubMed ID: 21170980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-free fed-batch culture of non-GS NS0 cell lines for production of recombinant antibodies.
    Burky JE; Wesson MC; Young A; Farnsworth S; Dionne B; Zhu Y; Hartman TE; Qu L; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):281-93. PubMed ID: 16933323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of cell lines for monoclonal antibody production.
    Alvin K; Ye J
    Methods Mol Biol; 2014; 1131():263-71. PubMed ID: 24515472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical safety evaluation of monoclonal antibodies.
    Lynch CM; Grewal IS
    Handb Exp Pharmacol; 2008; (181):19-44. PubMed ID: 18071940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State-of-the-art in downstream processing of monoclonal antibodies: process trends in design and validation.
    Marichal-Gallardo PA; Alvarez MM
    Biotechnol Prog; 2012 Jul; 28(4):899-916. PubMed ID: 22641473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants.
    Ma JK; Drossard J; Lewis D; Altmann F; Boyle J; Christou P; Cole T; Dale P; van Dolleweerd CJ; Isitt V; Katinger D; Lobedan M; Mertens H; Paul MJ; Rademacher T; Sack M; Hundleby PA; Stiegler G; Stoger E; Twyman RM; Vcelar B; Fischer R
    Plant Biotechnol J; 2015 Oct; 13(8):1106-20. PubMed ID: 26147010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative updating of approved biopharmaceuticals.
    Redwan el-RM
    Hum Antibodies; 2007; 16(3-4):137-58. PubMed ID: 18334749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-based cell culture systems--an alternative to in vivo production of monoclonal antibodies.
    Nagel A; Koch S; Valley U; Emmrich F; Marx U
    Dev Biol Stand; 1999; 101():57-64. PubMed ID: 10566776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in antibody manufacturing using mammalian cells.
    Morrow KJ
    Biotechnol Annu Rev; 2007; 13():95-113. PubMed ID: 17875475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies: methods and clinical laboratory applications.
    Nakamura RM
    Clin Physiol Biochem; 1983; 1(2-5):160-72. PubMed ID: 6396016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody production.
    Birch JR; Racher AJ
    Adv Drug Deliv Rev; 2006 Aug; 58(5-6):671-85. PubMed ID: 16822577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scale-up of monoclonal antibody purification processes.
    Aldington S; Bonnerjea J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):64-78. PubMed ID: 17224311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of hollow-fiber bioreactor systems for large-scale production of murine monoclonal antibodies.
    Evans TL; Miller RA
    Targeted Diagn Ther; 1990; 3():25-43. PubMed ID: 2131012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.